
Learn the Distal humeral endoprosthesis: Stanmore implants custom implant for revision surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Distal humeral endoprosthesis: Stanmore implants custom implant for revision surgical procedure.
Resection of solitary renal osseous metastases has been proven to offer a survival benefit to patients: (https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620x.82b1.0820062).
Endoprosthetic replacement following excision of metastases has also been shown to restore and preserve function and relieve pain and is advocated in patients with estimated survival greater than the time to rehabilitate i.e. greater than 6-12 months. Careful patient selection by way of thorough pre-operative clinical and radiological assessment plus liaison with oncology teams is essential to identify those patients most likely to benefit from such major surgery and to exclude those in whom the risks outweighs the potential benefits.
Purely diaphysial bone tumours and intercalary endoprosthetic replacements are rare; at the Royal Orthopaedic Hospital they represent 3% of endoprosthetic replacements. Aseptic loosening is the most common cause of mechanical failure of intercalary endoprosthetic replacements which necessitates challenging revision surgery to preserve function and control pain. Revision of modular intercalary endoprostheses may only require the loose end of the prosthesis to be revised, preserving the integrated portion of the implant, as in this case. (https://www.researchgate.net/profile/Sammy_Hanna2/publication/51213976_Custom_endoprosthetic_reconstruction_for_malignant_bone_disease_in_the_humeral_diaphysis/links/0f31752f6515fdca14000000/Custom-endoprosthetic-reconstruction-for-malignant-bone-disease-in-the-humeral-diaphysis.pdf)
Distal humeral endoprostheses are very uncommon implants. They typically utilise a cemented ulna component and a hinge mechanism to replace the humero-ulna joint, however in this case we were able to preserve the epicondylar attachments for the stabilising ligaments thus only a hemiarthroplasty was required. This implant has a silver coating (Agluna) to prevent prosthetic infection and hydroxyapatite attachment plates for the medial and lateral epicondyles to achieve osseointegration in an attempt to avoid recurrent aseptic loosening.

INDICATIONS
The indications for the index intercalary endoprosthetic replacement was to reconstruct a segmental humeral defect after resection of a solitary renal cell carcinoma metastasis, which is known to improve overall patient survival. Aseptic loosening is the most common indication for revision of humeral intercalary endoprostheses (other failure mechanisms may include infection, fracture, local recurrence). The implant is fabricated in two modular halves and bolted together after cementation proximally and distally. As described by McGrath et al. in 2011, revision surgery is facilitated by exchange only of the loose component, the well fixed component may be left in-situ as a new component can be manufactured that bolts into the well fixed component, which preserves bone stock. Where cortical bone around the site of loosening is adequate intra-operative dismantling of the modular prosthesis, debridement and re-cementation of the loose component is recommended (https://www.researchgate.net/profile/Sammy_Hanna2/publication/51213976_Custom_endoprosthetic_reconstruction_for_malignant_bone_disease_in_the_humeral_diaphysis/links/0f31752f6515fdca14000000/Custom-endoprosthetic-reconstruction-for-malignant-bone-disease-in-the-humeral-diaphysis.pdf).
If there is concern regarding stability of fixation, exchange of the loose component to a custom made intercalary prosthesis with hydroxyapatite coated extra-cortical plate (https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620x.99b12.bjj-2017-0213.r1). Where bone is inadequate for further fixation joint replacement, as in this case, is advocated.
SYMPTOMS & EXAMINATION
This patient was presented with with insidiously worsening pain in the arm and reduced elbow function five years after having a solitary renal metastasis resected and a modular intercalary endoprosthetic replacement. Dressing and washing were very uncomfortable, and he required a sling for comfort.
IMAGING
Radiographs showed gross loosening of the distal portion of the intercalary prosthesis but no obvious loosening of the proximal implant-cement interface. Satisfactory integration was confirmed proximally with CT. Routine serum inflammatory markers (CRP, ESR) were normal, thus no pre-revision aspiration was thought necessary.
ALTERNATIVE OPERATIVE TREATMENT
There are no alternative operative solutions other than revision surgery. Surgical options include revision to another intercalary prosthesis , re-cementation of the loose prosthesis or revision to a custom distal humeral endoprosthesis. Amputation would be indicated for a tumour in the distal humerus with neuromuscular involvement that would either compromise adequate tumour resection or leave a flail limb with vascular compromise.
NON-OPERATIVE MANAGEMENT
Non-operative management (analgesia and immobilisation in a sling) had failed in this case.
CONTRAINDICATIONS
Contraindications to revision surgery include prosthetic joint infection and medical co-morbidity precluding major surgery and anaesthesia.


24-hours of post-operative intravenous antibiotics.
Passive exercises supervised by physiotherapy for flexion and extension for the first two weeks out of a sling only. After two weeks can progress to active elbow flexion and after six weeks can progress to active elbow extension.
Removal of clips at two weeks.

There is limited data concerning the outcomes after distal humeral endoprostheses as they are such rare implants. Kulkarni et al. reported the outcomes of ten patients with such implants undertaken during a 30 year period in a single centre; after mean 8 years follow-up, three were revised for aseptic loosening but there were no other failures (https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.85B2.13524).
Endoprosthetic replacement of the distal humerus is one way of reconstructing the elbow after excision of a bone tumour. The advantages are immediate stability and the early return of function. The potential disadvantages include the likelihood of failure of the prosthesis at some stage either by wear of the bushes, loosening, infection or fracture. There are few reports of alternative allograft reconstruction of the distal humerus. The only other surgical alternative is above elbow amputation. Non-operative options may include definitive radiotherapy in radiosensitive tumours if surgery not indicated by multiple osseous metastases (e.g. Ewing’s sarcoma)
We would never advocate heavy load lifting or resistance gym exercises and would advocate functional (activities of daily living) rehabilitation goals.
Endoprosthetic replacement of the distal humerus is one way of reconstructing the elbow after excision of a bone tumour. The advantages are immediate stability and the early return of function. The potential disadvantages include the likelihood of failure of the prosthesis at some stage either by wear of the bushes, loosening, infection or fracture. There are few reports of alternative allograft reconstruction of the distal humerus. The only other surgical alternative is above elbow amputation. Non-operative options may include definitive radiotherapy in radiosensitive tumours if surgery not indicated by multiple osseous metastases (e.g. Ewing’s sarcoma)
We would never advocate heavy load lifting or resistance gym exercises and would advocate functional (activities of daily living) rehabilitation goals.
Reference
- orthoracle.com


































